ImmunoCentrix Corporation

ImmunoCentrix Corporation is an FDA-registered manufacturer and distributor of in-vitro diagnostic (IVD) devices headquartered in Canoga Park, California. The company specializes in immunodiagnostic and research products across five core technology platforms: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunofluorescence (IFA), Rapid Tests, and Serology assays. Their product portfolio exceeds 100 immunodiagnostic and research products targeting infectious disease, parasitology, and autoimmune disease diagnostics. ImmunoCentrix maintains FDA registration and holds ISO 13485:2016 and ISO 9001:2015 certifications, demonstrating compliance with medical device manufacturing quality and management system standards. The company manufactures products under strict ISO and FDA quality requirements and distributes globally through direct sales and distributor networks. They offer technical support services and competitively priced products designed for clinical laboratories, research institutions, and diagnostic centers. Manufacturing capabilities encompass bulk reagent preparation and quality assurance protocols consistent with IVD device regulatory requirements.